Follow BDSI We are a Specialty Pharmaceutical Company with a Focus in Pain and Addiction Technology Platform Product Pipeline Conferences/Webcasts BEMA® Technology A small, dissolvable polymer film for application to mucosal membranes (inner lining of cheek) which allows for transmucosal delivery of drugs. Access Product Pipeline Publications CURRENT INVESTOR PRESENTATION, DATED AUGUST 4, 2015 BDSI Reports Second Quarter 2015 Financial Results Monday, August 10, 2015, 8:00 a.m. Replay available until August 24, 2015 Domestic: 888-438-5524 International: 719-325-2435 Conference ID: 1010257 Webcast: http://public.viavid.com/player/index.php?id=115388 STAY INFORMED Get the latest details on our products and services. SIGN UP TOP NEWS BioDelivery Sciences to Participate at the Wells Fargo Securities 2015 Healthcare Conference and the FBR Second Annual Healthcare Conference BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble film) CII Approval of new formulation expected to allow ONSOLIS to return to U.S. market in 2016 View News HOME ABOUT BDSI MANAGEMENT TEAM BOARD OF DIRECTORS CORPORATE GOVERNANCE TECHNOLOGY PLATFORM BEMA® TECHNOLOGY PRODUCT PIPELINE ONSOLIS® BELBUCA BUNAVAIL™ INVESTOR RELATIONS SEC FILINGS SECTION 16 (INSIDER FILINGS) XBRL ANNUAL REPORT PRESENTATIONS & EVENTS INVESTOR ALERTS NEWS & MEDIA CONTACT DIRECTIONS EMPLOYMENT TERMS PRIVACY Copyright © 2015, All Rights Reserved | BioDelivery Sciences International, Inc. | Website Developed and Hosted by BizCom Web Services, Inc. | Sitemap

Follow BDSI PUBLICATIONS American Society of Addiction Medicine (ASAM) Annual Meeting (April 2014) - BUNAVAIL Posters TECHNOLOGY PLATFORM MENU BEMA Technology Onsolis® BELBUCA™ BUNAVAIL® STAY INFORMED Get the latest details on our products and services. SIGN UP TOP NEWS In a Move by the U.S. Department of Health and Human Services - Patient Limit on Access to Opioid Dependence Treatments to be Expanded BioDelivery Sciences to Present at the 6th Annual Credit Suisse Small & Mid Cap Conference and the Ladenburg Thalmann 2015 Healthcare Conference View News HOME ABOUT BDSI MANAGEMENT TEAM BOARD OF DIRECTORS CORPORATE GOVERNANCE TECHNOLOGY PLATFORM BEMA® TECHNOLOGY PRODUCT PIPELINE ONSOLIS® BELBUCA™ BUNAVAIL® INVESTOR RELATIONS SEC FILINGS SECTION 16 (INSIDER FILINGS) XBRL ANNUAL REPORT PRESENTATIONS & EVENTS INVESTOR ALERTS NEWS & MEDIA CONTACT DIRECTIONS EMPLOYMENT TERMS PRIVACY Copyright © 2015, All Rights Reserved | BioDelivery Sciences International, Inc. | Website Developed and Hosted by BizCom Web Services, Inc. | Sitemap